What influences complementary medicine use for children with eosinophilic esophagitis? Findings from a cross-sectional survey.

Hannan, N; Steel, A; Tiralongo, E; McMillan, SS

What influences complementary medicine use for children with eosinophilic esophagitis? Findings from a cross-sectional survey.

Hannan, N Steel, A

Tiralongo, E McMillan, SS

Permalink

Publisher:: Elsevier
Publication Type:: Journal Article
Citation:: Complementary Therapies in Clinical Practice, 2021, 45
Issue Date:: 2021-07-23

Closed Access

	Filename	Description	Size
	1-s2.0-S174438812100147X-main.pdf		470.72 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Hannan, N
dc.contributor.author	Steel, A https://orcid.org/0000-0001-6643-9444
dc.contributor.author	Tiralongo, E
dc.contributor.author	McMillan, SS
dc.date.accessioned	2021-10-12T04:46:11Z
dc.date.available	2021-07-19
dc.date.available	2021-10-12T04:46:11Z
dc.date.issued	2021-07-23
dc.identifier.citation	Complementary Therapies in Clinical Practice, 2021, 45
dc.identifier.issn	1744-3881
dc.identifier.issn	1873-6947
dc.identifier.uri	http://hdl.handle.net/10453/151062
dc.description.abstract	Background and purpose Utilization of complementary medicines (CMs) amongst children with eosinophilic esophagitis (EoE) in Australia is high. Carers' beliefs, perceptions and use of CM can influence the decision to use CM in children in their care. This study explores the factors influencing the use of CM for a child's EoE when the carer also uses CM. Materials and methods Carers of children aged 0–18 years with EoE participated in a national cross-sectional online survey, conducted in Australia between September 2018 and February 2019. Data analysis included bivariate analysis, Cramer's V, backwards stepwise logistic regression and binomial logistic regression. Results Of the 181 total survey responses, 165 (91.2 %) respondents indicated they had utilized some form of CM for themselves. Children whose carer had used some form of CM for themselves were more likely to have used CM than children whose carer had not used CM (OR 4.6; p = 0.001). Of the CM self-using carers, 125 (75.8 %) had also chosen to utilize CM for their child's EoE. Use of CM in children was more likely amongst children who had used a pharmaceutical for their EoE (OR 7.51; p = 0.010), and those whose carer had consulted with “other health practitioners or health workers” for their child's EoE (OR 5.34; p < 0.001) or had consulted with a chiropractor for themselves (OR 2.70; p = 0.029). Conclusion High CM self-use amongst carers is associated with their decision to also use CM for their child's EoE, a concern given the absence of evidence for CM's safety and efficacy in this population. CM use in this population warrants further attention. Effective conventional medicines for EoE are limited and utilization of CM amongst children with EoE in Australia is high. The recommendation of CM for children with EoE warrants further attention given the substantial concomitant pharmaceutical care, and the absence of evidence for CM's safety and efficacy in this population. Further research into the role of CM practitioners, products, and therapies in an integrative model between CM and conventional healthcare must be undertaken.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier
dc.relation.ispartof	Complementary Therapies in Clinical Practice
dc.relation.isbasedon	10.1016/j.ctcp.2021.101448
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1104 Complementary and Alternative Medicine, 1110 Nursing
dc.subject.classification	Complementary & Alternative Medicine
dc.title	What influences complementary medicine use for children with eosinophilic esophagitis? Findings from a cross-sectional survey.
dc.type	Journal Article
utslib.citation.volume	45
utslib.location.activity	England
utslib.for	1104 Complementary and Alternative Medicine
utslib.for	1110 Nursing
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2021-10-12T04:46:10Z
pubs.publication-status	Published
pubs.volume	45

Abstract:

Background and purpose Utilization of complementary medicines (CMs) amongst children with eosinophilic esophagitis (EoE) in Australia is high. Carers' beliefs, perceptions and use of CM can influence the decision to use CM in children in their care. This study explores the factors influencing the use of CM for a child's EoE when the carer also uses CM. Materials and methods Carers of children aged 0–18 years with EoE participated in a national cross-sectional online survey, conducted in Australia between September 2018 and February 2019. Data analysis included bivariate analysis, Cramer's V, backwards stepwise logistic regression and binomial logistic regression. Results Of the 181 total survey responses, 165 (91.2 %) respondents indicated they had utilized some form of CM for themselves. Children whose carer had used some form of CM for themselves were more likely to have used CM than children whose carer had not used CM (OR 4.6; p = 0.001). Of the CM self-using carers, 125 (75.8 %) had also chosen to utilize CM for their child's EoE. Use of CM in children was more likely amongst children who had used a pharmaceutical for their EoE (OR 7.51; p = 0.010), and those whose carer had consulted with “other health practitioners or health workers” for their child's EoE (OR 5.34; p < 0.001) or had consulted with a chiropractor for themselves (OR 2.70; p = 0.029). Conclusion High CM self-use amongst carers is associated with their decision to also use CM for their child's EoE, a concern given the absence of evidence for CM's safety and efficacy in this population. CM use in this population warrants further attention. Effective conventional medicines for EoE are limited and utilization of CM amongst children with EoE in Australia is high. The recommendation of CM for children with EoE warrants further attention given the substantial concomitant pharmaceutical care, and the absence of evidence for CM's safety and efficacy in this population. Further research into the role of CM practitioners, products, and therapies in an integrative model between CM and conventional healthcare must be undertaken.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/151062